ONCOLife Articles
Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer
ONCOLife | 15 April 2026
AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis
AI | 15 April 2026
Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer
ONCOLife | 13 April 2026
MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer
ONCOLife | 11 April 2026
New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy
ONCOLife | 10 April 2026
New Radio-Theranostic Promises to Broaden Targeted Radiation in Solid Tumors
ONCOLife | 4 April 2026
New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy
ONCOLife | 30 March 2026
New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities
ONCOLife
26 March 2026
BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026
ONCOLife
25 March 2026
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife
22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife
23 March 2026
Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife
17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife
20 March 2026
FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma
FDA & EMA
20 March 2026
Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery
ONCOLife
19 March 2026
Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target
ONCOLife
14 March 2026
Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity
ONCOLife
14 March 2026
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife
13 March 2026
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
